HCM
IBB icon

Horrell Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Horrell Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13.7K Hold
65
– – 0.01% 138
2026
Q2 		$12.4K Buy
+65
New +$11.2K 0.01% 144

Other funds holding IBB

Albion Financial Group
Albion Financial Group Salt Lake City, Utah $1.77B AUM 14.95% 1-Year Est. Return
Generali Investments CEE
Generali Investments CEE Prague, Czech Republic $2.11B AUM 18.35% 1-Year Est. Return
MinichMacGregor Wealth Management
MinichMacGregor Wealth Management Saratoga Springs, New York $620M AUM 32.35% 1-Year Est. Return
Investment House LLC
Investment House LLC Redondo Beach, California $2.25B AUM 30.44% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
NTV Asset Management
NTV Asset Management Charleston, West Virginia $1.08B AUM 23.94% 1-Year Est. Return
Old National Bancorp
Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return
Redstone Wealth Management
Redstone Wealth Management Oklahoma City, Oklahoma $159M AUM 31.94% 1-Year Est. Return
Folger Nolan Fleming Douglas Capital Management
Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.18B AUM 27.44% 1-Year Est. Return
Decker Retirement Planning
Decker Retirement Planning Levi, Utah $302M AUM 70.25% 1-Year Est. Return

Horrell Capital Management's IBB Position: Q3 2026 in Review

Horrell Capital Management held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 65 shares worth $13.7K. The position accounts for 0.01% of the portfolio, ranked #138.

Horrell Capital Management first reported a position in IBB in Q2 2026 and has held it in 2 quarters since. 303 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Horrell Capital Management held 65 shares of iShares Biotechnology ETF worth $13.7K as of Q3 2026.
  • Horrell Capital Management left its iShares Biotechnology ETF share count unchanged in Q3 2026.
  • iShares Biotechnology ETF made up 0.01% of Horrell Capital Management's portfolio in Q3 2026, its #138 holding.
  • Horrell Capital Management first reported a position in iShares Biotechnology ETF in Q2 2026 and has held it in 2 quarters since.
  • 303 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Horrell Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.